Cryo Cell International Inc (CCEL): Cost of Revenue
$7.38M
Year ended 2025-11-30
$6.87M
Trailing 12 months to 2026-05-31
-5.7%
3-year compound annual growth
-5.2%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-11-30 | $7.38M | -7.2% | 2026-02-27, From 2024-12-01 |
| 2024-11-30 | $7.95M | -5.3% | 2026-02-27, From 2023-12-01 |
| 2023-11-30 | $8.39M | -4.6% | 2025-02-28, From 2022-12-01 |
| 2022-11-30 | $8.79M | -2.2% | 2024-02-28, From 2021-12-01 |
| 2021-11-30 | $8.99M | -6.9% | 2023-02-28, From 2020-12-01 |
| 2020-11-30 | $9.66M | -3.8% | 2022-02-22, From 2019-12-01 |
| 2019-11-30 | $10.04M | +17.5% | 2021-03-01, From 2018-12-01 |
| 2018-11-30 | $8.54M | +27.0% | 2020-02-28, From 2017-12-01 |
| 2017-11-30 | $6.72M | n/a | 2019-02-28, From 2016-12-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Cryo Cell International Inc (CCEL) | 2025-11-30 | $7.38M | -7.2% |
| Charming Medical Ltd (MCTA) | 2026-03-31 | $35.2K | +127.0% |
| Viemed Healthcare, Inc. (VMD) | 2025-12-31 | $114.82M | +26.1% |
| Sotera Health Co (SHC) | 2025-12-31 | $518.08M | +4.0% |
| Progyny, Inc. (PGNY) | 2025-12-31 | $984.18M | +7.7% |
| Mangoceuticals, Inc. (MGRX) | 2025-12-31 | $54.4K | -41.7% |
| BioRestorative Therapies, Inc. (BRTX) | 2025-12-31 | $23.8K | -15.1% |
Compare CCEL, MCTA, VMD, SHC side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗